Progressive pigmentary purpura related to raloxifene

Authors

• Zulal Erbagci, Gazimuhtarpasa Bulvari. Gecit 1. No: 1/5, 27090 Gaziantep, Turkey. Tel. +90 342 3606060. Fax: +90 342 3603928. E-mail: zerbagci{at}yahoo.com
• Almila Tuncel, Departments of Dermatology, Gaziantep University Medical Faculty, Gaziantep, Turkey.
• Suna Erkilic, Departments of Pathology, Gaziantep University Medical Faculty, Gaziantep, Turkey.
• Mehtap Ozkur, Departments of Pharmacology, Gaziantep University Medical Faculty, Gaziantep, Turkey.

Abstract

Progressive pigmentary purpura is a rare condition characterized by lymphocytic capillaritis histologically causing various clinical entities which are also named as persistent pigmented purpuric dermatoses. It is generally idiopathic; however, rare cases secondary to drugs and various diseases have been reported. In this report we describe a case of progressive pigmentary purpura induced by raloxifene, a selective estrogen receptor modulator which is primarily used in the treatment and prevention of postmenopausal osteoporosis. As far as we know, no case of progressive pigmentary purpura has previously been reported as an adverse effect of raloxifene.

Article Type

Case Report

First Page

314

Last Page

316

Recommended Citation

Erbagci, Zulal; Tuncel, Almila; Erkilic, Suna; and Ozkur, Mehtap (2005) "Progressive pigmentary purpura related to raloxifene," Saudi Medical Journal: Vol. 26: Iss. 2, Article 26.
DOI: https://doi.org/10.15537/1658-3175.2842